Last week, Equity Briefing incorrectly reported that Albany Molecular Research (NASDAQ: AMRI) reported $0.01 earnings per share for the second quarter. Albany Molecular Research's actual earnings were $0.06 per share for the second quarter, beating the Thomson Reuters Consensus estimate of $0.02 by $.04.

---

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Equity Briefing via Thomson Reuters ONE
HUG#1632490

Copyright 2012 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.